The main focus of our group is to develop predictive models of transcriptional regulation by integrating large-scale datasets to shed light on regulatory processes that are condition-specific. In conjunction with experimental validation, we will leverage such techniques to identify functional variants and mechanisms of action driving disease.

CABM 236

Research

The Kreimer lab focuses on understanding which regulatory elements play a role in specific conditions, cells and tissues, how they interact to achieve transcriptional regulation and what are the mechanisms by which genetic variation in these non-coding regions drives disease in humans.

Specifically, five main objectives of the lab are: (1) Leveraging Massively Parallel Reporter Assays (MPRAs) to identify functional binding of TFs and their combinations during neural differentiation. (2) Identification of functional variants in non-coding regions and their downstream effects, in neuropsychiatric disorders. (3) Leveraging temporal data to model enhancer-promoter interactions. (4) Deciphering cell-type specific determinants of gene regulation by systematic comparison of genomic data across multiple cell types. (5) Develop models that can be used for efficient experimental design.

Our lab employs a multi-disciplinary approach, combining high-throughput genomic techniques with computational models, for annotation of the non-coding genome.  We develop methods that integrate multiple types of genomic, genetic and functional data, as well as facilitate close interactions with experimental and clinical labs.

Differential variability analysis of single-cell gene expression data
August 20, 2023
Differential variability analysis of single-cell gene expression data
Briefings in Bioinformatics

Read More › about Differential variability analysis of single-cell gene expression data

Characterization of De Novo Promoter Variants in Autism Spectrum Disorder with Massively Parallel Reporter Assays
February 9, 2023
Characterization of De Novo Promoter Variants in Autism Spectrum Disorder with Massively Parallel Reporter Assays
International Journal of Molecular Sciences

Read More › about Characterization of De Novo Promoter Variants in Autism Spectrum Disorder with Massively Parallel Reporter Assays

Massively parallel reporter perturbation assays uncover temporal regulatory architecture during neural differentiation
March 21, 2022
Massively parallel reporter perturbation assays uncover temporal regulatory architecture during neural differentiation
Nature Communications

Read More › about Massively parallel reporter perturbation assays uncover temporal regulatory architecture during neural differentiation

Conversations with CABM Director: An interview with Dr. Anat Kreimer
March 31, 2021
Conversations with CABM Director: An interview with Dr. Anat Kreimer
YouTube

Read More › about Conversations with CABM Director: An interview with Dr. Anat Kreimer

CABM welcomes Anat Kreimer as a resident faculty member
October 29, 2020
CABM welcomes Anat Kreimer as a resident faculty member

Read More › about CABM welcomes Anat Kreimer as a resident faculty member